Freedom to research in Australia - exemptions to patent infringement
By
We consider patent infringement exemptions of particular relevance to the life sciences.
The Prescription | December 2022
By
-
-
Discounting in the era of the Medicines Supply Security Guarantee
ByWe review the new stockholding and discounting requirements introduced by the Strategic Agreements with the Australian Government.
-
Aged Care and Other Legislation Amendment Act 2022 - what you need to know
ByThis article is part one in a series where we summarise the key amendments and the relevant commencement dates.
-
Is your ASX announcement advertising a therapeutic good?
ByThe TGA recently released its Guidance for ASX announcements addressing the need to comply with both therapeutic goods advertising requirements and continuous disclosure obligations
-
Patent settlement and licence agreements
ByWe analyse the recent high profile withdrawal of an application to the ACCC for authorisation of a patent litigation settlement by Juno and Celgene.
-
Government takes steps to deliver on ‘key commitment’ of strategic agreement with Medicines Australia
ByA reference committee has been appointed to conduct a review of the Health Technology Assessment policy and methods.
-
Functional antibody claims in Australia – what will happen if the bar is raised?
ByWe consider the Patent Office’s decision in Sanofi v Amgen and the future for functional antibody claims under the ‘Raising the Bar’ regime.
-
Tribunal decisions, consent, substitute decision makers and the use of restrictive practices in residential aged care – what can we learn?
ByWe summarise guidance from recent tribunal decisions on the use of restrictive practices in residential aged care services.
-
Restrictive practices in aged care – an update on consent
ByWe provide an update on changes to legislation regarding informed consent.
-
Indemnity costs in patent cases
ByWe assess the Federal Court’s approach to indemnity costs in recent patent cases.